The GnRH agonist d-Lys6-GnRH has served as a carrier to target chemotherapy agents or radionuclides to the GnRH receptor for cancer treatment or imaging [6, 9, 13, 14, 16, 26, 30–34]. The gene discussed is GNRHR; the disease is cancer.